104EGP
- Active ingredient
- metformin hydrochloride+vildagliptin
- Strength
- 50/500mg
- Form
- tablet
- Manufacturer
- future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in severe renal impairment, metabolic acidosis, and hypersensitivity to the components.
Side effects
Nausea, diarrhea, headache, dizziness, and gastrointestinal discomfort may occur.
Warnings
Monitor renal function and be alert for signs of lactic acidosis or pancreatitis.
How it works
Metformin reduces hepatic glucose production while vildagliptin enhances glucose-dependent insulin secretion through DPP-4 inhibition.
Storage
Store at room temperature away from moisture.